This could affect the ability of uromodulin to enhance the role of cFH as a cofactor in promoting C3b cleavage, potentially leading to insufficient inhibition of complement system activation, which may be one of the pathogenic mechanisms of ADTKD. The gene discussed is C3; the disease is autosomal dominant medullary cystic kidney disease with or without hyperuricemia.